---
title: "Repaglinide - Diabetes Mellitus Type 2"
sidebar: mydoc_sidebar
permalink: db00912-mesh-d003924-1.html
toc: false 
---


Path ID: `DB00912_MESH_D003924_1`
{% include image.html url="images/db00912-mesh-d003924-1.png" file="db00912-mesh-d003924-1.png" alt="db00912-mesh-d003924-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C072379 | repaglinide | Drug |
| UniProt:Q09428 | ATP-binding cassette sub-family C member 8 | Protein |
| REACT:R-HSA-422356 | Regulation of insulin secretion | Pathway |
| GO:0006006 | glucose metabolic process | BiologicalProcess |
| MESH:D003924 | Diabetes mellitus type 2 | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Repaglinide | DECREASES ACTIVITY OF | Atp-Binding Cassette Sub-Family C Member 8 |
| Atp-Binding Cassette Sub-Family C Member 8 | PARTICIPATES IN | Regulation Of Insulin Secretion |
| Regulation Of Insulin Secretion | REGULATES | Glucose Metabolic Process |
| Glucose Metabolic Process | CORRELATED WITH | Diabetes Mellitus Type 2 |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00912](https://go.drugbank.com/drugs/DB00912)
  - [https://en.wikipedia.org/wiki/Repaglinide#Mechanism_of_action](https://en.wikipedia.org/wiki/Repaglinide#Mechanism_of_action)
